Research and Markets: Biological Safety Testing Market - Expected to Grow at a CAGR of 12.23% to Reach $3,130.85 Million by 2019

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/n9ngwh/biological_safety) has announced the addition of the "Biological Safety Testing Market by Application, Product & Test - Global Forecast " report to their offering.

The global pharmaceutical industry is expected to grow at a CAGR between 5% and 8%. According to the IMS Institute of Healthcare Informatics, the global biologics market has increased from $46 billion in 2002 to $169 billion in 2012.

Biologics accounted for 11% of the total sales of drugs in 2002, which increased to 18% in 2012.

The biologics safety testing market is growing at a favorable rate. The major drivers for the market include growth of the pharmaceutical and biological industries and an increasing number of new drug launches.

It is estimated that this figure will rise to 20% by 2017, with a total market value of $221 billion. According to Ernst & Young's Global Biotechnology Report 2013, companies in biotech centers in the U.S., Europe, Canada, and Australia achieved revenues of about $90 billion in 2012. This was an 8% increase over their revenues in 2011.

Owing to the rise in the number of biotechnology companies, biopharmaceutical production has increased globally. Biologics safety testing is carried out at all levels of pharmaceutical and biopharmaceutical manufacturing process to minimize the risk of product contamination. Growth in pharmaceutical and biotechnology industries will drive the growth of the biologics safety testing market.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Biologics Safety Testing Market, By Application

8 Biologics Safety Testing Market, By Product

9 Biologics Safety Testing Market, By Test

10 Biologics Safety Testing Market, By Region

11 Competitive Landscape

12 Company Profiles

Companies Mentioned:

  • Avance Biosciences Inc.
  • BSL Bioservice
  • Charles River Laboratories International, Inc.
  • Cytovance Biologics, Inc.
  • Lonza Group
  • Merck & Co., Inc.
  • SGS S.A.
  • Sigma-Aldrich Corporation
  • Toxikon Corporation
  • Wuxi Pharmatech (Cayman) Inc.

For more information visit http://www.researchandmarkets.com/research/n9ngwh/biological_safety.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biopharmaceuticals, Biodefense

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biopharmaceuticals, Biodefense